Cigna (NYSE:CI): According to David Einhorn, Cigna, “Is a boring homework exercise with potential for big rewards. Even when HMOs make less than expected, they make a lot.” There is a great deal of apprehension about Obamacare which has made Health Maintenance Organizations or HMOs cheap. Cigna is a good choice, not only because of its high caliber and quick growth, but it trades at a discount.
Acorda Therapeutics (NASDAQ:ACOR): Following S&P’s announcement that they would be added to the S&P SmallCap 600 index, shares increased 3.7%.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Dara BioSciences (NASDAQ:DARA): After Nasdaq told the company that they regained compliance with Rule 5550(2), requiring a minimum bid $1.00 for continued listing, Dara BioSciences’s stocks increased by 3%. The firm also added that a special meeting of stockholders, scheduled for November 8, to look into a reverse stock split proposal dealing with the issue, has been aborted.
DaVita (NYSE:DVA): After ending a seven year civil and criminal examination into the Dialysis clinic operator’s financial and marketing practices, the Department of Justice has decided not to file charges against DaVita. Their shares gained 0.6%.
Cynosure (NASDAQ:CYNO): After filing to sell 2.94 million shares for holders, Cynosure’s stock declined by 5%.
Don’t Miss: AstraZeneca’s New Strategy.